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INTRODUCTION
Persistent migraine aura without infarction is a rare but 
well documented condition. According to the International 
Headache Society (HIS) criteria, this disturbance is defined 
by the persistence of a migraine aura for more than one week 
without radiographic evidence of infarction.1
Here we describe the case of an 11-year-old girl suffering 
from migraine without aura since the age of four. She 
experienced two episodes of persistent negative visual aura 
with no evidence of infarction. To the best of our knowledge, 
this is the first Brazilian case reported in the literature. 
Interestingly this patient demonstrated a clinical recovery 
following treatment with oral furosemide.
CASE REPORT
An 11-year-old girl was admitted to our headache 
unit complaining of headache associated with a persistent 
negative phenomenon (“shadow” in the eyes) that interfered 
with her visual function. The week prior to assessment she 
experienced a transitory neurological symptom described as 
bright zigzag lines in her temporal visual fields. A similar 
episode occurred six months before, with persistence of the 
visual field defect for four months. She had a 7-year history 
of migraine without aura, and her family history was positive 
for migraine with aura in her father.
Neurological examination was normal, except for right 
hemianopsia. This finding was confirmed by ophthalmologic 
examination, including computerized campimetry. Magnetic 
resonance neuroimaging studies comprising T1, T2, and 
FLAIR sequences were unrevealing.
The patient was prescribed atenolol at a dosage of 25 
mg daily. She displayed remission of the headache, but 
persistence of the negative visual phenomenon. Forty 
milligrams of Furosemide p.o. daily was then prescribed, 
with subsequent complete resolution of the visual symptoms 
in five days. This medication was discontinued during 
follow-up, and no further visual aura emerged. 
DISCUSSION
Persistent visual symptoms lasting several days without 
infarction are rare complications of migraine. This condition 
was first described in a 65-year-old woman who developed 
such a phenomenon that persisted for over 12 months despite 
treatment.2 A total of 29 cases were identified in the literature 
by a recent review.3 This migraine-related complication seems 
to be more common in women. The youngest patient reported 
was nine, and the oldest was 70 years of age. It is worth 
mentioning that other aura phenomena, such as numbness, 
paraesthesia, and even clumsiness, may be persistent.3,4 
The pathophysiology of prolonged visual aura is not 
understood, but several mechanisms are probably involved, 
including sustained reverberating waves of cortical spreading 
depression.5 There is no radiographic evidence of infarction, 
but functional neuroimaging studies have demonstrated 
cortical blood hypoperfusion in certain cerebral areas.2,6-8
Drugs such as carbamazepine, tricyclics, nifedipine, 
flunarizine, beta blockers, and analgesics were not helpful 
in the treatment of persistent aura.2,7 Drugs that act on 
cortical spreading depression, such as valproic acid 
and lamotrigine, have been proposed to be of value.5,6,8 
Furosemide is also a very effective therapeutic option, 
providing symptom resolution in a few days following 
intravenous administration.4,9 The rationale for using 
furosemide is its effect on potassium, a key element in the 
first steps of cortical spreading depression.9,10 
Our patient probably experienced spontaneous resolution 
of her first episode of persistent visual aura. In the second 
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episode, oral furosemide may have contributed to the 
resolution of her symptoms. Further studies are necessary 
to confirm the efficacy of furosemide in this context. 
Nevertheless, this report and others support furosemide as 
a reasonable option for the treatment of persistent visual 
migraine aura. 
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